+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)

Dermatological Drugs Market Research Reports

Difamilast Market Drug Insight and Market Forecast - 2032 - Product Thumbnail Image

Difamilast Market Drug Insight and Market Forecast - 2032

  • Drug Pipelines
  • December 2022
  • 30 Pages
  • Global
From
Abrocitinib Market Drug Insight and Market Forecast - 2032 - Product Thumbnail Image

Abrocitinib Market Drug Insight and Market Forecast - 2032

  • Drug Pipelines
  • December 2022
  • 30 Pages
  • Global
From
REMICADE Market Drug Insight and Market Forecast - 2032 - Product Thumbnail Image

REMICADE Market Drug Insight and Market Forecast - 2032

  • Drug Pipelines
  • December 2022
  • 30 Pages
  • Global
From
HUMIRA Market Drug Insight and Market Forecast - 2032 - Product Thumbnail Image

HUMIRA Market Drug Insight and Market Forecast - 2032

  • Drug Pipelines
  • December 2022
  • 30 Pages
  • Global
From
OPZELURA Market Drug Insight and Market Forecast - 2032 - Product Thumbnail Image

OPZELURA Market Drug Insight and Market Forecast - 2032

  • Drug Pipelines
  • December 2022
  • 30 Pages
  • Global
From
KPL-716 Emerging Drug Insight and Market Forecast - 2032 - Product Thumbnail Image

KPL-716 Emerging Drug Insight and Market Forecast - 2032

  • Report
  • September 2022
  • 30 Pages
  • Global
From
LOU064 Emerging Drug Insight and Market Forecast - 2032 - Product Thumbnail Image

LOU064 Emerging Drug Insight and Market Forecast - 2032

  • Report
  • September 2022
  • 30 Pages
  • Global
From
From
From
Hidradenitis Suppurativa (HS) - Epidemiology Forecast - 2032 - Product Thumbnail Image

Hidradenitis Suppurativa (HS) - Epidemiology Forecast - 2032

  • Report
  • September 2022
  • 95 Pages
  • Global
From
Global Moderate to Severe Acne - Pipeline Insight, 2022 - Product Thumbnail Image

Global Moderate to Severe Acne - Pipeline Insight, 2022

  • Drug Pipelines
  • August 2022
  • 70 Pages
  • Global
From
Ligelizumab Emerging Drug Insight and Market Forecast - 2032 - Product Thumbnail Image

Ligelizumab Emerging Drug Insight and Market Forecast - 2032

  • Report
  • August 2022
  • 30 Pages
  • Global
From
From
From
Dystrophic Epidermolysis Bullosa - Epidemiology Forecast - 2032 - Product Thumbnail Image

Dystrophic Epidermolysis Bullosa - Epidemiology Forecast - 2032

  • Report
  • August 2022
  • 100 Pages
  • Global
From
From
From
From
Hand Eczema (HE) - Epidemiology Forecast - 2032 - Product Thumbnail Image

Hand Eczema (HE) - Epidemiology Forecast - 2032

  • Report
  • July 2022
  • 98 Pages
  • Global
From
From
Loading Indicator

The Dermatological Drugs market is a sector of the pharmaceutical industry that focuses on the development and production of drugs used to treat skin conditions. These drugs are used to treat a variety of skin conditions, including acne, eczema, psoriasis, and skin cancer. Dermatological drugs are typically administered topically, although some may be taken orally. The Dermatological Drugs market is highly competitive, with many companies vying for market share. Major players in the market include Johnson & Johnson, GlaxoSmithKline, Pfizer, Merck, and Novartis. These companies are engaged in research and development of new drugs, as well as marketing and distribution of existing products. Additionally, many smaller companies are involved in the production of generic dermatological drugs. Show Less Read more